US Patent Issued to REGENERON PHARMACEUTICALS on March 18 for "Human antibodies to Fel d1 and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,530, issued on March 18, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Human antibodies to Fel d1 and methods of use thereof" was invented by Jamie Orengo (Cortlandt Manor, N.Y.) and Andrew J. Murphy (Croton-on-Hudson, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides antibodies that bind to the cat allergen, Fel d1, compositions comprising the antibodies, nucleic acids encoding the antibodies and methods of use of the antibodies. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to Fel d1. The antibodies of the invention are useful for bindin...